Skip to main content
Erschienen in: American Journal of Clinical Dermatology 5/2017

01.10.2017 | Systematic Review

Risk of Suicidality in People with Psoriasis: A Systematic Review and Meta-Analysis of Cohort Studies

verfasst von: Ching-Chi Chi, Ting-Hao Chen, Shu-Hui Wang, Tao-Hsin Tung

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Psoriasis has been associated with psychiatric disorders such as depression and anxiety, but its relationship with suicidality (including suicide, suicide attempt, and suicidal ideation) is unclear.

Objective

Our objective was to assess the risk of suicide, suicide attempt, suicidal ideation, and suicidality in people with psoriasis.

Methods

We conducted a systematic review and meta-analysis of cohort studies examining the risk of suicide, suicide attempt, suicidal ideation, and suicidality in people with psoriasis. We searched the Cochrane Library, PubMed, and EMBASE from inception to 24 March 2017. Two authors independently selected studies, assessed the quality of included studies, and extracted data. Any disagreement was resolved by discussion with a third author.

Results

Five population-based cohort studies were included and considered to be of high quality. We found no increase in the risk of suicide (risk ratio [RR] 1.13; 95% confidence interval [CI] 0.87–1.46), suicide attempt (RR 1.25; 95% CI 0.89–1.75), or suicidality (RR 1.26; 95% CI 0.97–1.64) among people with psoriasis. In the stratified analysis, we also found no increase in suicide, suicide attempt, and suicidality among people with either severe or mild psoriasis.

Conclusions

The available limited, very low-quality evidence does not support an association between psoriasis and suicidal thought and behavior. Further studies that provide data for different age and sex groups are needed to clarify whether a subgroup of patients with psoriasis has an elevated risk of suicidality.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ko WC, Tsai TF, Tang CH. Health state utility, willingness to pay, and quality of life among Taiwanese patients with psoriasis. Dermatol Sin. 2016;34(4):185–91.CrossRef Ko WC, Tsai TF, Tang CH. Health state utility, willingness to pay, and quality of life among Taiwanese patients with psoriasis. Dermatol Sin. 2016;34(4):185–91.CrossRef
2.
3.
Zurück zum Zitat Chi CC, Wang J, Chen YF, Wang SH, Chen FL, Tung TH. Risk of incident chronic kidney disease and end-stage renal disease in patients with psoriasis: a nationwide population-based cohort study. J Dermatol Sci. 2015;78(3):232–8.CrossRefPubMed Chi CC, Wang J, Chen YF, Wang SH, Chen FL, Tung TH. Risk of incident chronic kidney disease and end-stage renal disease in patients with psoriasis: a nationwide population-based cohort study. J Dermatol Sci. 2015;78(3):232–8.CrossRefPubMed
4.
Zurück zum Zitat Yang YW, Keller JJ, Lin HC. Medical comorbidity associated with psoriasis in adults: a population-based study. Br J Dermatol. 2011;165(5):1037–43.CrossRefPubMed Yang YW, Keller JJ, Lin HC. Medical comorbidity associated with psoriasis in adults: a population-based study. Br J Dermatol. 2011;165(5):1037–43.CrossRefPubMed
5.
Zurück zum Zitat Yang HJ, Yang KC. Impact of psoriasis on quality of life in Taiwan. Dermatol Sin. 2015;33(3):146–50.CrossRef Yang HJ, Yang KC. Impact of psoriasis on quality of life in Taiwan. Dermatol Sin. 2015;33(3):146–50.CrossRef
6.
Zurück zum Zitat Tu HP, Yu CL, Lan CCE, Yu S. Prevalence of schizophrenia in patients with psoriasis: a nationwide study. Dermatol Sin. 2017;35(1):1–6.CrossRef Tu HP, Yu CL, Lan CCE, Yu S. Prevalence of schizophrenia in patients with psoriasis: a nationwide study. Dermatol Sin. 2017;35(1):1–6.CrossRef
7.
Zurück zum Zitat Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010;146(8):891–5.PubMedPubMedCentral Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010;146(8):891–5.PubMedPubMedCentral
8.
Zurück zum Zitat Waisman A, Hauptmann J, Regen T. The role of IL-17 in CNS diseases. Acta Neuropathol. 2015;129(5):625–37.CrossRefPubMed Waisman A, Hauptmann J, Regen T. The role of IL-17 in CNS diseases. Acta Neuropathol. 2015;129(5):625–37.CrossRefPubMed
9.
Zurück zum Zitat Mina VA, Lacerda-Pinheiro SF, Maia LC, Pinheiro RF Jr, Meireles CB, de Souza SI, et al. The influence of inflammatory cytokines in physiopathology of suicidal behavior. J Affect Dis. 2015;172:219–30.CrossRefPubMed Mina VA, Lacerda-Pinheiro SF, Maia LC, Pinheiro RF Jr, Meireles CB, de Souza SI, et al. The influence of inflammatory cytokines in physiopathology of suicidal behavior. J Affect Dis. 2015;172:219–30.CrossRefPubMed
10.
Zurück zum Zitat Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12.CrossRefPubMed Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12.CrossRefPubMed
12.
Zurück zum Zitat Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Chichester: Wiley-Blackwell; 2008.CrossRef Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Chichester: Wiley-Blackwell; 2008.CrossRef
13.
Zurück zum Zitat Singhal A, Ross J, Seminog O, Hawton K, Goldacre MJ. Risk of self-harm and suicide in people with specific psychiatric and physical disorders: comparisons between disorders using English national record linkage. J R Soc Med. 2014;107(5):194–204.CrossRefPubMedPubMedCentral Singhal A, Ross J, Seminog O, Hawton K, Goldacre MJ. Risk of self-harm and suicide in people with specific psychiatric and physical disorders: comparisons between disorders using English national record linkage. J R Soc Med. 2014;107(5):194–204.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Egeberg A, Hansen PR, Gislason GH, Skov L, Mallbris L. Risk of self-harm and nonfatal suicide attempts, and completed suicide in patients with psoriasis: a population-based cohort study. Br J Dermatol. 2016;175(3):493–500.CrossRefPubMed Egeberg A, Hansen PR, Gislason GH, Skov L, Mallbris L. Risk of self-harm and nonfatal suicide attempts, and completed suicide in patients with psoriasis: a population-based cohort study. Br J Dermatol. 2016;175(3):493–500.CrossRefPubMed
15.
Zurück zum Zitat Kimball AB, Wu EQ, Guerin A, Yu AP, Tsaneva M, Gupta SR, et al. Risks of developing psychiatric disorders in pediatric patients with psoriasis. J Am Acad Dermatol. 2012;67(4):651–7.CrossRefPubMed Kimball AB, Wu EQ, Guerin A, Yu AP, Tsaneva M, Gupta SR, et al. Risks of developing psychiatric disorders in pediatric patients with psoriasis. J Am Acad Dermatol. 2012;67(4):651–7.CrossRefPubMed
16.
Zurück zum Zitat Wu JJ, Penfold RB, Primatesta P, Fox TK, Stewart C, Reddy SP, et al. The risk of depression, suicidal ideation, and suicide attempt in patients with psoriasis, psoriatic arthritis, or ankylosing spondylitis. J Eur Acad Dermatol Venereol. 2017;. doi:10.1111/jdv.14175 (Epub 18 Feb 2017). Wu JJ, Penfold RB, Primatesta P, Fox TK, Stewart C, Reddy SP, et al. The risk of depression, suicidal ideation, and suicide attempt in patients with psoriasis, psoriatic arthritis, or ankylosing spondylitis. J Eur Acad Dermatol Venereol. 2017;. doi:10.​1111/​jdv.​14175 (Epub 18 Feb 2017).
17.
Zurück zum Zitat Al-Sharifi A, Krynicki CR, Upthegrove R. Self-harm and ethnicity: a systematic review. Int J Soc Psychiatry. 2015;61(6):600–12.CrossRefPubMed Al-Sharifi A, Krynicki CR, Upthegrove R. Self-harm and ethnicity: a systematic review. Int J Soc Psychiatry. 2015;61(6):600–12.CrossRefPubMed
18.
Zurück zum Zitat Evans C. Managed care aspects of psoriasis and psoriatic arthritis. Am J Manag Care. 2016;22(8 Suppl):s238–43.PubMed Evans C. Managed care aspects of psoriasis and psoriatic arthritis. Am J Manag Care. 2016;22(8 Suppl):s238–43.PubMed
19.
20.
Zurück zum Zitat Chen YJ, Chen YY, Wu CY, Chi CC. Oral Chinese herbal medicine in combination with phototherapy for vitiligo: a systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2016;26:21–7.CrossRefPubMed Chen YJ, Chen YY, Wu CY, Chi CC. Oral Chinese herbal medicine in combination with phototherapy for vitiligo: a systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2016;26:21–7.CrossRefPubMed
21.
Zurück zum Zitat Chen TH, Tung TH, Chen PS, Wang SH, Chao CM, Hsiung NH, et al. The clinical effects of aromatherapy massage on reducing pain for the cancer patients: meta-analysis of randomized controlled trials. Evid Based Complement Altern Med. 2016;2016:9147974. Chen TH, Tung TH, Chen PS, Wang SH, Chao CM, Hsiung NH, et al. The clinical effects of aromatherapy massage on reducing pain for the cancer patients: meta-analysis of randomized controlled trials. Evid Based Complement Altern Med. 2016;2016:9147974.
22.
Zurück zum Zitat Chi CC, Wang SH, Wojnarowska F, Kirtschig G, Davies E, Bennett C. Safety of topical corticosteroids in pregnancy. Cochrane Database Syst Rev. 2015;26(10):CD007346. Chi CC, Wang SH, Wojnarowska F, Kirtschig G, Davies E, Bennett C. Safety of topical corticosteroids in pregnancy. Cochrane Database Syst Rev. 2015;26(10):CD007346.
23.
Zurück zum Zitat Chi CC, Wang SH, Kirtschig G. Safety of topical corticosteroids in pregnancy. JAMA Dermatol. 2016;152(8):934–5.CrossRefPubMed Chi CC, Wang SH, Kirtschig G. Safety of topical corticosteroids in pregnancy. JAMA Dermatol. 2016;152(8):934–5.CrossRefPubMed
Metadaten
Titel
Risk of Suicidality in People with Psoriasis: A Systematic Review and Meta-Analysis of Cohort Studies
verfasst von
Ching-Chi Chi
Ting-Hao Chen
Shu-Hui Wang
Tao-Hsin Tung
Publikationsdatum
01.10.2017
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 5/2017
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-017-0281-1

Weitere Artikel der Ausgabe 5/2017

American Journal of Clinical Dermatology 5/2017 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Studienlage spricht für Isotretinoin zur Rosazea-Therapie

23.05.2024 Rosazea Nachrichten

Isotretinoin wird off-label zur Behandlung von Rosazea eingesetzt. Wie solide die Evidenz dafür ist, wurde jetzt in einem systematischen Review überprüft.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.